Literature DB >> 31954339

Identifying hypertension in pregnancy using electronic medical records: The importance of blood pressure values.

Lu Chen1, Susan M Shortreed2, Thomas Easterling3, T Craig Cheetham4, Kristi Reynolds5, Lyndsay A Avalos6, Aruna Kamineni7, Victoria Holt3, Romain Neugebauer6, Mary Akosile7, Nerissa Nance6, Zoe Bider-Canfield5, Rod L Walker7, Sylvia E Badon6, Sascha Dublin2.   

Abstract

OBJECTIVE: To incorporate blood pressure (BP), diagnoses codes, and medication fills from electronic medical records (EMR) to identify pregnant women with hypertension. STUDY
DESIGN: A retrospective cohort study of singleton pregnancies at three US integrated health delivery systems during 2005-2014. MAIN OUTCOME MEASURES: Women were considered hypertensive if they had any of the following: (1) ≥2 high BPs (≥140/90 mmHg) within 30 days during pregnancy (High BP); (2) an antihypertensive medication fill in the 120 days before pregnancy and a hypertension diagnosis from 1 year prior to pregnancy through 20 weeks gestation (Treated Chronic Hypertension); or (3) a high BP, a hypertension diagnosis, and a prescription fill within 7 days during pregnancy (Rapid Treatment). We described characteristics of these pregnancies and conducted medical record review to understand hypertension presence and severity.
RESULTS: Of 566,624 pregnancies, 27,049 (4.8%) met our hypertension case definition: 24,140 (89.2%) with High BP, 5,409 (20.0%) with Treated Chronic Hypertension, and 5,363 (19.8%) with Rapid Treatment (not mutually exclusive). Of hypertensive pregnancies, 19,298 (71.3%) received a diagnosis, 9,762 (36.1%) received treatment and 11,226 (41.5%) had a BP ≥ 160/110. In a random sample (n = 55) of the 7,559 pregnancies meeting the High BP criterion with no hypertension diagnosis, clinical statements about hypertension were found in medical records for 58% of them.
CONCLUSION: Incorporating EMR BP identified many pregnant women with hypertension who would have been missed by using diagnosis codes alone. Future studies should seek to incorporate BP to study treatment and outcomes of hypertension in pregnancy.
Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31954339      PMCID: PMC7096129          DOI: 10.1016/j.preghy.2020.01.001

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  29 in total

Review 1.  White-coat hypertension: new insights from recent studies.

Authors:  Stanley S Franklin; Lutgarde Thijs; Tine W Hansen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

Review 2.  Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.

Authors:  Mark A Brown; Laura A Magee; Louise C Kenny; S Ananth Karumanchi; Fergus P McCarthy; Shigeru Saito; David R Hall; Charlotte E Warren; Gloria Adoyi; Salisu Ishaku
Journal:  Hypertension       Date:  2018-07       Impact factor: 10.190

3.  Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery.

Authors:  David A Savitz; Valery A Danilack; Beth Elston; Heather S Lipkind
Journal:  Am J Epidemiol       Date:  2014-05-30       Impact factor: 4.897

4.  Linking mothers and infants within electronic health records: a comparison of deterministic and probabilistic algorithms.

Authors:  Eric Baldwin; Karin Johnson; Heidi Berthoud; Sascha Dublin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-11-18       Impact factor: 2.890

5.  Descriptive epidemiology of chronic hypertension, gestational hypertension, and preeclampsia in New York State, 1995-2004.

Authors:  David A Savitz; Valery A Danilack; Stephanie M Engel; Beth Elston; Heather S Lipkind
Journal:  Matern Child Health J       Date:  2014-05

6.  Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals.

Authors:  Pedro L Teixeira; Wei-Qi Wei; Robert M Cronin; Huan Mo; Jacob P VanHouten; Robert J Carroll; Eric LaRose; Lisa A Bastarache; S Trent Rosenbloom; Todd L Edwards; Dan M Roden; Thomas A Lasko; Richard A Dart; Anne M Nikolai; Peggy L Peissig; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2016-08-07       Impact factor: 4.497

7.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

Authors:  Anne B Wallis; Audrey F Saftlas; Jason Hsia; Hani K Atrash
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

8.  Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants.

Authors:  Roland Lennestål; Petra Otterblad Olausson; Bengt Källén
Journal:  Eur J Clin Pharmacol       Date:  2009-02-07       Impact factor: 2.953

9.  Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus.

Authors:  Susan E Spratt; Katherine Pereira; Bradi B Granger; Bryan C Batch; Matthew Phelan; Michael Pencina; Marie Lynn Miranda; Ebony Boulware; Joseph E Lucas; Charlotte L Nelson; Benjamin Neely; Benjamin A Goldstein; Pamela Barth; Rachel L Richesson; Isaretta L Riley; Leonor Corsino; Eugenia R McPeek Hinz; Shelley Rusincovitch; Jennifer Green; Anna Beth Barton; Carly Kelley; Kristen Hyland; Monica Tang; Amanda Elliott; Ewa Ruel; Alexander Clark; Melanie Mabrey; Kay Lyn Morrissey; Jyothi Rao; Beatrice Hong; Marjorie Pierre-Louis; Katherine Kelly; Nicole Jelesoff
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

10.  Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study.

Authors:  Chen-Yi Su; Herng-Ching Lin; Hsin-Chung Cheng; Amy Ming-Fang Yen; Yi-Hua Chen; Senyeong Kao
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more
  4 in total

1.  Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.

Authors:  Sascha Dublin; Abisola Idu; Lyndsay A Avalos; T Craig Cheetham; Thomas R Easterling; Lu Chen; Victoria L Holt; Nerissa Nance; Zoe Bider-Canfield; Romain S Neugebauer; Kristi Reynolds; Sylvia E Badon; Susan M Shortreed
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.752

2.  Gestational weight gain and adverse pregnancy outcomes by pre-pregnancy BMI category in women with chronic hypertension: A cohort study.

Authors:  Sylvia E Badon; Sascha Dublin; Nerissa Nance; Monique M Hedderson; Romain Neugebauer; Thomas Easterling; T Craig Cheetham; Lu Chen; Victoria L Holt; Lyndsay A Avalos
Journal:  Pregnancy Hypertens       Date:  2020-10-24       Impact factor: 2.899

3.  Prevalence of Hypertension Among Pregnant Women When Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines and Association With Maternal and Fetal Outcomes.

Authors:  Natalie A Bello; Hui Zhou; T Craig Cheetham; Eliza Miller; Darios T Getahun; Michael J Fassett; Kristi Reynolds
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  The Impact of Different Degrees of Intraventricular Hemorrhage on Mortality and Neurological Outcomes in Very Preterm Infants: A Prospective Cohort Study.

Authors:  Yong Wang; Juan Song; Xiaoli Zhang; Wenqing Kang; Wenhua Li; Yuyang Yue; Shan Zhang; Falin Xu; Xiaoyang Wang; Changlian Zhu
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.